You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
利爾化學(002258.SZ):津滬深醫藥通過中通投資間接持有公司6853.79萬股
格隆匯 12-21 18:14

格隆匯 12 月 21日丨利爾化學(002258.SZ)公佈,公司於2020年12月21日分別收到津滬深生物醫藥科技有限公司(“津滬深醫藥”)、天津渤海國有資產經營管理有限公司(“渤海國資”)提交的《簡式權益變動報告書》。鑑於天津市醫藥集團有限公司(“天藥集團”)進行混合所有制改革,津滬深醫藥通過在天津產權交易中心公開摘牌取得渤海國資持有的天藥集團67%股權,2020年12月19日,渤海國資與津滬深醫藥簽署了《產權交易合同》等有關法律文件。

由於天藥集團通過其全資子公司天津金耀集團有限公司間接控股天津藥業集團有限公司之全資子公司津耀發展有限公司(“津耀發展”),同時,津耀發展持有公司第二大股東中通投資有限公司(“中通投資”)80%股權,成為中通投資之間接控股股東,故津滬深醫藥通過中通投資間接持有公司股份;渤海國資不再間接控制中通投資,轉為間接參股。

此次權益變動前,津滬深醫藥未直接或間接持有公司股份;渤海國資通過中通投資間接持有公司13.07%的股份。此次權益變動後,津滬深醫藥通過中通投資間接持有公司6853.79萬股,間接持股比例為13.07%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account